<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 15 Dec 2025 11:02:11 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>EU Clears Generic Sleep Aid for Seniors With Insomnia</title><link>https://www.medscape.com/viewarticle/eu-clears-generic-sleep-aid-seniors-insomnia-2025a1000z5j?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>The EMA concluded that Melatomed’s benefits outweigh its risks and supported granting marketing authorizations in Germany, Austria, Denmark, and Swede...</description><pubDate>Mon, 15 Dec 2025 15:28:19 GMT</pubDate></item><item><title>New EGFR Lung Cancer Drug Nears EU Approval</title><link>https://www.medscape.com/viewarticle/new-egfr-lung-cancer-drug-nears-eu-approval-2025a1000z55?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events than standard therapy. Me...</description><pubDate>Mon, 15 Dec 2025 14:59:32 GMT</pubDate></item><item><title>First European Guide on Light Therapy in Cancer Care</title><link>https://www.medscape.com/viewarticle/first-european-guide-light-therapy-cancer-care-2025a1000z3d?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>AFSOS 2025 introduced the first European reference for photobiomodulation, outlining the evidence, dosing, and clinical use in supportive cancer care....</description><pubDate>Mon, 15 Dec 2025 12:16:13 GMT</pubDate></item><item><title>Immunome's Tumor Drug Meets Main Goal in Late-stage Study</title><link>https://www.medscape.com/s/viewarticle/immunomes-tumor-drug-meets-main-goal-late-stage-study-2025a1000z4c?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 34...</description><pubDate>Mon, 15 Dec 2025 12:16:13 GMT</pubDate></item><item><title>SMC Approves Givinostat for Duchenne Patients in Scotland</title><link>https://www.medscape.com/viewarticle/smc-approves-givinostat-duchenne-patients-scotland-2025a1000z1m?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care. Medscape News UK</description><pubDate>Mon, 15 Dec 2025 12:08:55 GMT</pubDate></item></channel></rss>